These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31621654)

  • 1. A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility.
    Del Giudice F; Busetto GM; De Berardinis E; Sperduti I; Ferro M; Maggi M; Gross MS; Sciarra A; Eisenberg ML
    Asian J Androl; 2020; 22(4):360-367. PubMed ID: 31621654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of aromatase inhibitors to treat male infertility.
    Yang C; Li P; Li Z
    Hum Reprod Update; 2021 Dec; 28(1):30-50. PubMed ID: 34871401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitors for male infertility.
    Raman JD; Schlegel PN
    J Urol; 2002 Feb; 167(2 Pt 1):624-9. PubMed ID: 11792932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of letrozole on spermogram parameters and hormonal profile in infertile men: A clinical trial study.
    Peivandi S; Jafarpour H; Abbaspour M; Ebadi A
    Endocr Regul; 2019 Oct; 53(4):231-236. PubMed ID: 31734656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors for male infertility.
    Schlegel PN
    Fertil Steril; 2012 Dec; 98(6):1359-62. PubMed ID: 23103016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover.
    Clark RV; Sherins RJ
    J Androl; 1989; 10(3):240-7. PubMed ID: 2663800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of male infertility secondary to morbid obesity.
    Roth MY; Amory JK; Page ST
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):415-9. PubMed ID: 18523426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone-estradiol ratio: A meta-analysis and systematic review.
    Guo B; Li JJ; Ma YL; Zhao YT; Liu JG
    Andrology; 2022 Jul; 10(5):894-909. PubMed ID: 35438843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do men with normal testosterone-oestradiol ratios benefit from letrozole for the treatment of male infertility?
    Shuling L; Sie Kuei ML; Saffari SE; Jiayun Z; Yeun TT; Leng JPW; Viardot-Foucault V; Nadarajah S; Chan JKY; Hao TH
    Reprod Biomed Online; 2019 Jan; 38(1):39-45. PubMed ID: 30449700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological non-hormonal treatment options for male infertility: a systematic review and network meta-analysis.
    Al Wattar BH; Rimmer MP; Teh JJ; Mackenzie SC; Ammar OF; Croucher C; Anastasiadis E; Gordon P; Pacey A; McEleny K; Sangster P
    BMC Urol; 2024 Jul; 24(1):158. PubMed ID: 39075435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men.
    Shoshany O; Abhyankar N; Mufarreh N; Daniel G; Niederberger C
    Fertil Steril; 2017 Mar; 107(3):589-594. PubMed ID: 28069178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone.
    Zumoff B; Miller LK; Strain GW
    Metabolism; 2003 Sep; 52(9):1126-8. PubMed ID: 14506617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of aromatase inhibitor letrozole in NOA with an elevated FSH level: a case report.
    Zhao D; Pan L; Zhang F; Pan F; Ma J; Zhang X; Liu Y
    Andrologia; 2014 May; 46(4):456-7. PubMed ID: 23803162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials.
    Ribeiro MA; Gameiro LF; Scarano WR; Briton-Jones C; Kapoor A; Rosa MB; El Dib R
    JBRA Assist Reprod; 2016 May; 20(2):82-8. PubMed ID: 27244767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios.
    Gregoriou O; Bakas P; Grigoriadis C; Creatsa M; Hassiakos D; Creatsas G
    Fertil Steril; 2012 Jul; 98(1):48-51. PubMed ID: 22579129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oestrogen modulation on semen parameters in men with secondary hypogonadism: Systematic review and meta-analysis.
    de Silva NL; Dissanayake H; Suarez C; Wickramarachchi RE; Ramasamy R; Dhillo WS; Minhas S; Corona G; Jayasena CN
    Andrology; 2024 Feb; 12(2):259-276. PubMed ID: 37306109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a treatable endocrinopathy in infertile men.
    Pavlovich CP; King P; Goldstein M; Schlegel PN
    J Urol; 2001 Mar; 165(3):837-41. PubMed ID: 11176482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply of the Authors: Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole.
    Naelitz BD; Lundy SD; Nowacki AS
    Fertil Steril; 2024 Jul; 122(1):190. PubMed ID: 38616033
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary on "Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole".
    Li D; Zeng X
    Fertil Steril; 2024 Jul; 122(1):189. PubMed ID: 38494104
    [No Abstract]   [Full Text] [Related]  

  • 20. Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole.
    Naelitz BD; Jiang T; Munoz-Lopez C; Sigalos JT; Modiri N; Cannarella R; Mills JN; Parekh N; Nowacki AS; Vij SC; Eleswarapu SV; Lundy SD
    Fertil Steril; 2023 Oct; 120(4):746-754. PubMed ID: 37392782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.